Puerarin exerted anti-osteoporotic action independent of estrogen receptor-mediated pathway

Journal of Nutritional Science and Vitaminology

Volumn 58, Issue 3, 2012, Pages 202-209

  Michihara, Seiwa ^a   Tanaka, Teruyoshi ^a   Uzawa, Yuki ^a   Moriyama, Tatsuya ^a   Kawamura, Yukio ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Anti osteoporosis; Bone loss; Estrogen receptor; Kudzu; Puerarin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; DAIDZEIN; DEOXYPYRIDINOLINE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; OSTEOCALCIN; PUERARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOSTEOPOROTIC ACTIVITY; ARTICLE; BONE ATROPHY; BONE METABOLISM; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; FEMUR; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSSIFICATION; OVARIECTOMY;

EID: 84930481252     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.58.202     Document Type: Article

References (21)

1. Chien KR, Karsenty G. 2005. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell 120: 533-544.
2. Delmas PD. 2002. Treatment of postmenopausal osteoporosis. Lancet 359: 2018-2026.
3. Raisz LG. 2005. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115: 3318-3325.
4. Rodan GA, MartinTJ. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514.
5. Teitelbaum SL. 2007. Osteoclasts: what do they do and how do they do it? Am J Pathol 170: 427-435.
6. Riggs BL, Hartmann LC. 2003. Selective estrogenreceptor modulators-mechanisms of action and application to clinical practice. N Engl J Med 348: 618-629.
7. Leclercq G, Heuson JC. 1979. Physiological and pharmacological effects of estrogens in breast cancer. Biochim Biophys Acta 560: 427-455.
8. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 39: 4252-4263.
9. Setchell KD. 1998. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333S-1346S.
10. Uesugi T, Toda T, Tsuji K, Ishida H. 2001. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull 24: 368-372.
11. Lee YB, Lee HJ, Kim KS, Lee JY, Nam SY, Cheon SH, Sohn HS. 2004. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci Biotechnol Biochem 68: 1040-1045.
12. Gu L, House SE, Prior RL, Fang N, Ronis MJ, Clarkson TB, Wilson ME, Badger TM. 2006. Metabolic phenotype of isoflavones differs among female rats, pigs, monkeys, and women. J Nutr 136: 1215-1221.
13. Ishimi Y, Arai N, Wang X, Wu J, Umegaki K, Miyaura C, Takeda A, Ikegami S. 2000. Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem Biophys Res Commun 274: 697-701.
14. Michihara S, Suzuki S, Tang H, Moriyama T, Kawamura Y. 2008. Kudzu (Pueraria lobata) extracts depress bone absorption of ovariectomized mouse by downregulating NFATc1 of osteoclast. J Clin Biochem Nutr 43: 141-144.
15. Ishida H, Uesugi T, Hirai K, Toda T, Nukaya H, Yokotsuka K, Tsuji K. 1998. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 21: 62-66.
16. Tanaka T, Tang H, Yu F, Michihara S, Uzawa Y, Zaima N, Moriyama T, Kawamura Y. 2011. Kudzu (Pueraria lobata) vine ethanol extracts improve ovariectomyinduced bone loss in female mice. J Agric Food Chem 59: 13230-13237.
17. Hwang YP, Jeong HG. 2008. Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: ER-dependent up-regulation of PI3K/Akt and HO-1. Toxicol Appl Pharmacol 233: 371-381.
18. Xu X, Hu Y, Ruan Q. 2004. Effects of puerarin on learning-memory and amino acid transmitters of brain in ovariectomized mice. Planta Med 70: 627-631.
19. Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. 2003. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod 66: 788-792.
20. Hu W, Yang X, Zhe C, Zhang Q, Sun L, Cao K. 2011. Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-B activation in LPS-induced RAW264.7 macrophage cells. Pharmacol Rep 63: 781-789.
21. Prasain JK, Peng N, Moore R, Arabshahi A, Barnes S, Wyss JM. 2009. Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography-tandem mass spectrometry. Phytomedicine 16: 65-71.